Obesity and Cancer Metabolism: A Perspective on Interacting Tumor–Intrinsic and Extrinsic Factors

by Steven S. Doerstling, Ciara H. O’Flanagan, Stephen D. Hursting, Stephen D. Hursting, Stephen D. Hursting
Published 2017-09-01

Mechanistic Targets and Phytochemical Strategies for Breakingthe Obesity-Cancer Link

by Nikki A Ford, Laura M Lashinger, Emma H Allott, Stephen D Hursting, Stephen D Hursting
Published 2013-08-01

Dietary Energy Modulation and Autophagy: Exploiting Metabolic Vulnerabilities to Starve Cancer

by Alyssa J. Cozzo, Alyssa J. Cozzo, Michael F. Coleman, Jane B. Pearce, Alexander J. Pfeil, Suhas K. Etigunta, Stephen D. Hursting, Stephen D. Hursting, Stephen D. Hursting
Published 2020-11-01

Mechanistic Targets and Nutritionally Relevant Intervention Strategies to Break Obesity–Breast Cancer Links

by Ximena M. Bustamante-Marin, Jenna L. Merlino, Emily Devericks, Meredith S. Carson, Stephen D. Hursting, Stephen D. Hursting, Delisha A. Stewart, Delisha A. Stewart
Published 2021-03-01

Differential Effects of Calorie Restriction and Exercise on the Adipose Transcriptome in Diet-Induced Obese Mice

by Karrie E. Wheatley, Leticia M. Nogueira, Susan N. Perkins, Stephen D. Hursting
Published 2011-01-01

Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator microRNA-504.

by Nikki A Ford, Sarah M Dunlap, Karrie E Wheatley, Stephen D Hursting
Published 2013-01-01

When less may be more: calorie restriction and response to cancer therapy

by Ciara H. O’Flanagan, Laura A. Smith, Shannon B. McDonell, Stephen D. Hursting
Published 2017-05-01

Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy

by Michael F. Coleman, Alyssa J. Cozzo, Alexander J. Pfeil, Suhas K. Etigunta, Stephen D. Hursting
Published 2020-04-01

Risk profiles for weight gain among postmenopausal women: a classification and regression tree analysis approach.

by Su Yon Jung, Mara Z Vitolins, Jenifer Fenton, Alexis C Frazier-Wood, Stephen D Hursting, Shine Chang
Published 2015-01-01

Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer.

by Kaylyn L Devlin, Tiffany Sanford, Lauren M Harrison, Paul LeBourgeois, Laura M Lashinger, Elizabeth Mambo, Stephen D Hursting
Published 2016-01-01

Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor...

by Alison E Harvey, Laura M Lashinger, Drew Hays, Lauren M Harrison, Kimberly Lewis, Susan M Fischer, Stephen D Hursting
Published 2014-01-01

Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.

by Laura W Bowers, Megan Wiese, Andrew J Brenner, Emily L Rossi, Rajeshwar R Tekmal, Stephen D Hursting, Linda A deGraffenried
Published 2015-01-01

Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression.

by Susan E Olivo-Marston, Stephen D Hursting, Susan N Perkins, Aaron Schetter, Mohammed Khan, Carlo Croce, Curtis C Harris, Jackie Lavigne
Published 2014-01-01

Pyruvate carboxylase and cancer progression

by Violet A. Kiesel, Madeline P. Sheeley, Michael F. Coleman, Eylem Kulkoyluoglu Cotul, Shawn S. Donkin, Stephen D. Hursting, Michael K. Wendt, Dorothy Teegarden
Published 2021-04-01

Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction

by Michael F. Coleman, Ciara H. O’Flanagan, Alexander J. Pfeil, Xuewen Chen, Jane B. Pearce, Susan Sumner, Sergey A. Krupenko, Stephen D. Hursting
Published 2021-05-01

Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer

by Ciara H. O’Flanagan, Emily L. Rossi, Shannon B. McDonell, Xuewen Chen, Yi-Hsuan Tsai, Joel S. Parker, Jerry Usary, Charles M. Perou, Stephen D. Hursting
Published 2017-07-01

Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity

by Youssef W. Naguib, Dharmika Lansakara-P., Laura M. Lashinger, B. Leticia Rodriguez, Solange Valdes, Mengmeng Niu, Abdulaziz M. Aldayel, Lan Peng, Stephen D. Hursting, Zhengrong Cui
Published 2016-01-01